How many months should kidney transplant patients usually take Valganciclovir?

The timing of taking Valganciclovir is critical in patients undergoing kidney transplantation to prevent cytomegalovirus (CMV) infection due to immunosuppression. Usually, doctors will start giving Vancevir to patients as soon as possible after the kidney transplant surgery is completed, that is, within 10 days after the operation. For adult patients, the recommended dose is 900mg once a day, and the entire course of treatment should last until the 200th day after transplantation, which is approximately more than 6 months. This stage is when the patient's immune system is most vulnerable, and the risk of CMV infection is high, so antiviral preventive treatment is particularly critical.

For children aged 4 months to 16 years old who are undergoing kidney transplantation, the dosage needs to be accurately calculated based on body surface area (BSA) and creatinine clearance (CrCl). The general recommended dosage formula is: daily dose = 7 x BSA x CrCl. Children also need to start taking medication within 10 days after transplantation and continue until 200 days after surgery. The reason why it needs to be taken for such a long time is because CMV has a long incubation period and a high recurrence rate after transplantation. Once infected, it may not only cause serious complications such as fever, pneumonia, gastrointestinal bleeding, but also accelerate graft rejection, posing a great threat to the patient's recovery.

It should be noted that while taking Vancevir, both adult and pediatric patients should receive regular blood routine, renal function and CMV viral load monitoring to prevent adverse reactions such as neutropenia or renal function damage caused by the drug. If a patient experiences serious side effects, doctors may adjust the dose or suspend treatment on a case-by-case basis. In short, as an important means of antiviral prevention after kidney transplantation, the dosage cycle of Vancevir for about 6 months is a standard length established based on clinical research and guidelines. Patients should strictly adhere to the medication according to the doctor's recommendations to minimize the risk of CMV infection.

Reference materials:https://go.drugbank.com/drugs/DB01610